900 related articles for article (PubMed ID: 15388289)
1. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
Liu J; Schulteis G
Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
[TBL] [Abstract][Full Text] [Related]
2. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
Schulteis G; Morse AC; Liu J
Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
[TBL] [Abstract][Full Text] [Related]
3. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.
Schulteis G; Morse AC; Liu J
Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849
[TBL] [Abstract][Full Text] [Related]
4. Discrete cues paired with naloxone-precipitated withdrawal from acute morphine dependence elicit conditioned withdrawal responses.
Amitai N; Liu J; Schulteis G
Behav Pharmacol; 2006 May; 17(3):213-22. PubMed ID: 16571999
[TBL] [Abstract][Full Text] [Related]
5. Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze.
Zhang Z; Schulteis G
Pharmacol Biochem Behav; 2008 May; 89(3):392-403. PubMed ID: 18308382
[TBL] [Abstract][Full Text] [Related]
6. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
Azar MR; Jones BC; Schulteis G
Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
8. Relative potency of the opioid antagonists naloxone and 6-alpha-naloxol to precipitate withdrawal from acute morphine dependence varies with time post-antagonist.
Schulteis G; Chiang D; Archer C
Pharmacol Biochem Behav; 2009 Mar; 92(1):157-63. PubMed ID: 19061911
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
10. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
Sobor M; Timár J; Riba P; Friedmann T; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
Brain Res Bull; 2011 Jan; 84(1):53-60. PubMed ID: 20934489
[TBL] [Abstract][Full Text] [Related]
11. Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake.
Holtz NA; Radke AK; Zlebnik NE; Harris AC; Carroll ME
Brain Res; 2015 Mar; 1602():119-26. PubMed ID: 25582876
[TBL] [Abstract][Full Text] [Related]
12. Brain reward deficits accompany withdrawal (hangover) from acute ethanol in rats.
Schulteis G; Liu J
Alcohol; 2006 May; 39(1):21-8. PubMed ID: 16938626
[TBL] [Abstract][Full Text] [Related]
13. Severe deficit in brain reward function associated with fentanyl withdrawal in rats.
Bruijnzeel AW; Lewis B; Bajpai LK; Morey TE; Dennis DM; Gold M
Biol Psychiatry; 2006 Mar; 59(5):477-80. PubMed ID: 16169528
[TBL] [Abstract][Full Text] [Related]
14. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure.
Schulteis G; Heyser CJ; Koob GF
Psychopharmacology (Berl); 1997 Jan; 129(1):56-65. PubMed ID: 9122364
[TBL] [Abstract][Full Text] [Related]
15. Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats.
Wiebelhaus JM; Walentiny DM; Beardsley PM
J Pharmacol Exp Ther; 2016 Jan; 356(1):43-52. PubMed ID: 26491062
[TBL] [Abstract][Full Text] [Related]
16. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
17. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
Dong Z; Han H; Cao J; Xu L
Hippocampus; 2010 Feb; 20(2):335-43. PubMed ID: 19437411
[TBL] [Abstract][Full Text] [Related]
18. Orexin type 1 receptor antagonism in Lateral Paragigantocellularis nucleus attenuates naloxone precipitated morphine withdrawal symptoms in rats.
Ahmadi-Soleimani SM; Ghaemi-Jandabi M; Azizi H; Semnanian S
Neurosci Lett; 2014 Jan; 558():62-6. PubMed ID: 24211689
[TBL] [Abstract][Full Text] [Related]
19. Baclofen reestablishes micro-opioid receptor levels modified by morphine withdrawal syndrome in either sex.
Diaz SL; Kemmling AK; Bonavita CD; Rubio MC; Balerio GN
Synapse; 2004 Oct; 54(1):24-9. PubMed ID: 15300881
[TBL] [Abstract][Full Text] [Related]
20. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
